Allosterism occurs when a ligand binds to a receptor on a binding site distinct from the orthosteric one to which endogenous ligand normally binds. Among the G protein-coupled receptors (GPCRs), the adenosine receptors (ARs), classified as A1, A2A, A2B, and A3 are the first known to be allosterically regulated. The first part of this chapter has focused on the mechanism behind the allosteric modulation on GPCRs, and specifically on ARs. To date, three main mechanisms have been recognized, namely: (1) the allosteric transition, due to the transition from the inactive to the active state; (2) the receptor dimerization; and (3) the ligand of exogenous or endogenous ligands. In the second part, an overview on the medicinal chemistry of adenosine allosteric modulators, in terms of chemical structure and structure–activity relationships, has been reported, highlighting the most outstanding advances in the development of AR modulators endowed with therapeutic potential.

Allosteric Modulators of Adenosine Receptors

Barresi, Elisabetta
Co-primo
;
Giacomelli, Chiara
Co-primo
;
Martini, Claudia;Da Settimo, Federico;Trincavelli, Maria Letizia
Penultimo
;
Taliani, Sabrina
Ultimo
2022-01-01

Abstract

Allosterism occurs when a ligand binds to a receptor on a binding site distinct from the orthosteric one to which endogenous ligand normally binds. Among the G protein-coupled receptors (GPCRs), the adenosine receptors (ARs), classified as A1, A2A, A2B, and A3 are the first known to be allosterically regulated. The first part of this chapter has focused on the mechanism behind the allosteric modulation on GPCRs, and specifically on ARs. To date, three main mechanisms have been recognized, namely: (1) the allosteric transition, due to the transition from the inactive to the active state; (2) the receptor dimerization; and (3) the ligand of exogenous or endogenous ligands. In the second part, an overview on the medicinal chemistry of adenosine allosteric modulators, in terms of chemical structure and structure–activity relationships, has been reported, highlighting the most outstanding advances in the development of AR modulators endowed with therapeutic potential.
2022
Barresi, Elisabetta; Giacomelli, Chiara; Martini, Claudia; Da Settimo, Federico; Trincavelli, Maria Letizia; Taliani, Sabrina
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1185308
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact